Form 4 for JBIO Jade Biosciences, Inc.
Accepted 2022-11-22 00:00:00 ET · period of report 2022-11-18 · accession 0001415889-22-011708 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-11-22 | 2022-11-18+ | JBIO | Eldridge George A | SEE REMARKS | S - Sale+OE | $19.43 | -1,037 | 1,960 | -35% | -$20.1K |
| DM | 2022-11-22 | 2022-11-18+ | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +1,037 | 2,821 | +58% | +$2,219 |
| DM | 2022-11-22 | 2022-11-18+ | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $0.00 | -1,037 | 97.8K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-22 | S | D | 174 | $19.01 | 1,960 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.00 to $19.03, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 2 | Common | Common Stock | 2022-11-21 | M | A | 2 | $2.14 | 1,962 | D | — | — | |
| 3 | Common | Common Stock | 2022-11-21 | S | D | 2 | $19.00 | 1,960 | D | — | — | |
| 4 | Common | Common Stock | 2022-11-22 | M | A | 174 | $2.14 | 2,134 | D | — | — | |
| 5 | Common | Common Stock | 2022-11-18 | S | D | 780 | $19.45 | 2,041 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.06 to $20.045, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 6 | Common | Common Stock | 2022-11-18 | M | A | 861 | $2.14 | 2,821 | D | — | — | (F2) Includes 1,960 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on October 31, 2022 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d). |
| 7 | Common | Common Stock | 2022-11-18 | S | D | 81 | $20.13 | 1,960 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.095 to $20.29, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 8 | Derivative | Stock Option (Right to Buy) | 2022-11-18 | M | D | 861 | $0.00 | 97,815 | D | $2.14 · — to 2031-04-01 | 861 Common Stock | (F6) A total of 98,676 shares subject to an employee stock option were granted on April 1, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter. |
| 9 | Derivative | Stock Option (Right to Buy) | 2022-11-22 | M | D | 174 | $0.00 | 97,639 | D | $2.14 · — to 2031-04-01 | 174 Common Stock | (F6) A total of 98,676 shares subject to an employee stock option were granted on April 1, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter. |
| 10 | Derivative | Stock Option (Right to Buy) | 2022-11-21 | M | D | 2 | $0.00 | 97,813 | D | $2.14 · — to 2031-04-01 | 2 Common Stock | (F6) A total of 98,676 shares subject to an employee stock option were granted on April 1, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter. |